Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing

Johnson & Johnson (NYSE: JNJ)


Last Updated: Dec-09-2016 19:59:03

Recent Market News

Today's Johnson & Johnson Stock Update

Here's a daily update on the Johnson & Johnson stock price for interested investors, plus some key data on JNJ stock that's important to know. While we frequently give readers a more detailed Johnson & Johnson stock price analysis, you can get a quick rundown of key JNJ numbers here, for December 10, 2016.Let's start with where JNJ stock closed yesterday - at $112.26. From the previous trading session Johnson & Johnson shares went up 1.14% or $1.27 .It's best to not only look at recent Johnson & Johnson share data, but also look at the year's highs and lows to see where the current price stacks up...At today's price, JNJ is trading at a higher price than it was one-year ago, with shares having gone up by 9.90%.

TRENDING: The 4 Best Gold Stocks to Buy Now - One's Up 200% in 2016

The Johnson & Johnson stock price 52-week high is $126.07. That was hit on 7/20/2016. The JNJ stock 52-week low is $94.28, reached on 1/21/2016.Another number to look at - JNJ trading volume yesterday was 7,774,900. That's more than Johnson & Johnson stock's average daily trading volume of 7,672,821.Johnson & Johnson's market cap is 307,129,888,000. That gives Johnson & Johnson a mega market cap, because it's over 200 billion. As of the beginning of April, Apple has the biggest market cap of all publicly traded companies.

TRENDING: The Best Stocks in the World Are on Sale Now - We Like These 5

The current P/E (price/earnings) ratio of Johnson & Johnson stock is 16.99. That's smaller than the March 2016 S&P 500 P/E ratio of about 23. To really gauge if this stock's P/E is high or low, you should compare JNJ to other companies in the same industry.The current EPS (earnings per share) of JNJ is 5.65.Beta - how closely the stock trades with the overall market, with a beta of 1 meaning it trades in step with the broader index -- for Johnson & Johnson is 0.72.Johnson & Johnson stock has a dividend yield of 2.88%. Generally a dividend yield of 2% or more is decent for those investors who want income from dividend stocks.Money Morning gives you Johnson & Johnson stock news daily. We publish new info on JNJ and dozens of other key companies we're watching now, every day, so investors will never miss an opportunity. As always, our content is free.

UP NEXT: This stock is one of the most promising "double" opportunities on the market today - meaning we expect shares to gain 100% from where they are now. The biggest price catalyst is this company is set to dominate virtual reality. Get it's name and a chance to double your money here.

Click here to read more stories

Premium Research

Johnson & Johnson (NYSE: JNJ) Profile

Volume7,672,000
Open$111.41
Prior Close$110.99
Market Cap$307.13 B
PE Ratio16.97
Beta0.72
Johnson & Johnson is engaged in the research and development manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer Pharmaceutical and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care skin care oral care wound care and women's health fields nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective antipsychotic contraceptive dermatology gastrointestinal hematology immunology neurology oncology pain management thrombosis vaccines and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction spinal care neurological and sports medicine products; surgical care aesthetics and women's health products. Johnson & Johnson is based in New Brunswick New Jersey.
SymbolCompanyMarket cap
PFEPfizer Inc$187.75 B
RHHBYRoche Hldg Ltd Spons$184.62 B
MRKMerck & Company$165.76 B
NVSNovartis Ag$160.56 B
SNYSanofi-Aventis Sa$102.38 B
ABBVAbbvie Inc Common Stock$98.97 B
BMYBristol-Myers Squibb Company$92.3 B
GSKGlaxosmithkline Plc$91.16 B
NVONovo Nordisk A/S$88.38 B
BAYRYBayer Aktienges Ads$81.79 B

JNJ Earnings

1st Quarter Earnings$1.68 (2016-10-18)
2nd Quarter Earnings$1.74 (2016-07-19)
3rd Quarter Earnings$1.68 (2016-04-19)
4th Quarter Earnings$1.44 (2016-01-26)
PE Ratio16.97
EPS Growth8.25%
Recent Earnings$1.68
Annual EPS$6.54
Market Capitalization$307.13 B
Insider Shareholder %0.0011%
Annual Revenue$71.6 B
Number of Shares Outstanding2,735,880 Shares
Institutional Shareholder %64.13%
Annual Net Income$15.78B
TTM Net Profit Margin$22.04
One Year Return13.52%
Three Year Return26.99%
Five Year Return105.5%
Five Year Revenue Growth13.78%
Five Year Earnings Growth30.25%
Five Year Dividend Growth39.81%
Last Quarter EPS$1.68
Annual EPS$6.54
Annual Dividend$3.2
Annual Dividend Yield2.88%
Change in EPS YTD8.25%
PE Ratio16.97
Recent Earnings$1.68
Dividends per Share$0.8
Stock Split Ratio2-1
beta0.72

JNJ Key Stats

Last Price$112.26
Net Change$1.27 (1.14%)
Bid$0
Ask Price$0
Open Price$111.41
Previous Close Price$110.99
High Price$112.43
Low Price$111.2
Number of Trades30,437
Volume7,672,000
Fifty Two Week High$126.07 (2016-07-20)
Fifty Two Week Low$94.28 (2016-01-21)
Average Daily Volume7,682,081
Share Outstanding2,735,880 Shares
Total Dividend Payout$3.2/yr
Dividend Yield2.88%